Literature DB >> 6745299

Uptake of 75Se-selenocholesterol by an adrenal cortical carcinoma and its metastases.

E Reschini, M Peracchi.   

Abstract

Adrenal scintigraphy with 75Se-selenocholesterol was performed in a patient with Cushing's syndrome due to a right adrenal tumor. The tumor was faintly but clearly imaged. The liver was sharply imaged and the liver uptake did not reveal the usual decrease after the first week postinjection. The liver image was still clearly evident in the last scintiphotos taken 26 days after injection of radiocholesterol. At operation a right adrenocortical carcinoma was removed and the right lobe of the liver was found to be almost completely replaced by metastatic adrenal tissue.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6745299     DOI： 10.1007/BF00803255

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  13 in total

1.  [Adrenal scintigraphy using 131 I-19-iodocholesterol. Value in the exploration of Cushing's syndrome].

Authors:  B Charbonnel; J F Chatal; M Chupin; J Guillon
Journal:  Nouv Presse Med       Date:  1976-12-11

2.  Uptake of 131I-19-iodocholesterol by an adrenal cortical carcinoma and its metastases.

Authors:  J F Chatal; B Charbonnel; B P Le Mevel; D Guihard
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

Review 3.  Adrenal scintigraphy.

Authors:  J H Thrall; J E Freitas; W H Beierwaltes
Journal:  Semin Nucl Med       Date:  1978-01       Impact factor: 4.446

4.  Localization of a metastatic adrenal carcinoma using 131-I-19-iodocholesterol.

Authors:  B H Forman; M A Antar; R J Touloukian; P J Mulrow; M Genel
Journal:  J Nucl Med       Date:  1974-05       Impact factor: 10.057

5.  Scintigraphic detection of hepatic metastases with 131I-labeled steroid in recurrent adrenal carcinoma: case report.

Authors:  K Watanabe; I Kamoi; C Nakayama; I Koga; K Matsuura
Journal:  J Nucl Med       Date:  1976-10       Impact factor: 10.057

6.  Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.

Authors:  L A Hawkins; K E Britton; B Shapiro
Journal:  Br J Radiol       Date:  1980-09       Impact factor: 3.039

7.  Detection of metastatic adrenal carcinoma using 131I-6-beta-iodomethyl-19-norcholesterol total body scans.

Authors:  J E Seabold; T P Haynie; D N DeAsis; N A Samaan; H J Glenn; M F Jahns
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

8.  Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.

Authors:  D E Schteingart; J E Seabold; M D Gross; D P Swanson
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

9.  [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].

Authors:  F A Leger; E Requeda; G Reach; P F Plouin; J C Savoie
Journal:  Nouv Presse Med       Date:  1981-02-14

10.  [A new radiotracer for scintigraphy of the adrenal glands: 6-methyl-Se75-selenocholesterol. Its value in comparison with 131-I-19-iodocholesterol].

Authors:  J F Chatal; B Charbonnel; R Guihard
Journal:  Nouv Presse Med       Date:  1977-04
View more
  3 in total

Review 1.  A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.

Authors:  E Reschini; M Baldini; L Cantalamessa
Journal:  Eur J Nucl Med       Date:  1990

2.  Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.

Authors:  E Reschini; A Catania
Journal:  Eur J Nucl Med       Date:  1991

Review 3.  Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.

Authors:  Iosif A Mendichovszky; Andrew S Powlson; Roido Manavaki; Franklin I Aigbirhio; Heok Cheow; John R Buscombe; Mark Gurnell; Fiona J Gilbert
Journal:  Diagnostics (Basel)       Date:  2016-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.